Bacteriostatic Antibiotics Market to Witness Steady Growth Rate to
2026 Including Global Top Players Allergan Plc., Pfizer Inc., Mylan
N.V., Sun Pharmaceutical Industries Ltd., Akorn Inc., Tetraphase
Pharmaceuticals, Inc.
Antibiotics are naturally occurring or artificially produced
substances, which are widely used in the treatment of bacterial
diseases. Antibiotics works by killing bacteria (bactericidal effect)
or by inhibiting their growth (bacteriostatic effect). Although
bacteriostatic antibiotics prevent bacterial growth and reproduction,
it does not necessarily kill them.
Ask
For Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2307
Bacteriostatic Antibiotics Market Drivers
Global bacteriostatic antibiotics market is expected to witness a
significant growth over the forecast period, owing to recent approval
and launch of novel bacteriostatic antibiotics products in the
market. For instance, in September 2018, Tetraphase Pharmaceuticals,
Inc., a biopharmaceutical company dedicated to development,
manufacturing, and commercialization of novel antibiotics for treat
life-threatening multidrug-resistant (MDR) infections received
European Commission (EC) marketing authorization for its novel
bacteriostatic antibiotic namely XERAVA (eravacycline) injection,
which is indicated for the treatment of complicated intra-abdominal
infections (cIAI) in adults in the European Union. XERAVA
(Eravacycline) is a fluorocycline antibacterial within the
tetracycline class of antibacterial drugs, it is bacteriostatic
against gram-positive bacteria (e.g., Staphylococcus aureus and
Enterococcus faecalis).
Bacteriostatic Antibiotics Market Regional Analysis
North America bacteriostatic antibiotics market is expected to hold a
dominant position in the global Bacteriostatic Antibiotics Market and
account for largest market share over the forecast period, owing to
presence of key players and approval and launch of novel
bacteriostatic antibiotics drugs by them in the region. For instance,
in August 2018, Tetraphase Pharmaceuticals, Inc., a Massachusetts,
U.S-based biopharmaceutical company, received the U.S. Food and Drug
Administration (FDA) approval for its novel bacteriostatic
antibiotics namely XERAVA (eravacycline) for the treatment of
complicated intra-abdominal infections (cIAI)
Bacteriostatic Antibiotics Market Key Players
Key players operating in global Bacteriostatic Antibiotics Market
include
1. Tetraphase Pharmaceuticals, Inc.
2. Allergan Plc.
3. Pfizer Inc.
4. Mylan N.V.
5. Sun Pharmaceutical Industries Ltd.
6. Hikma Pharmaceuticals Plc.
7. Akorn Inc., and Others
Bacteriostatic Antibiotics Market Taxonomy:
The global bacteriostatic antibiotics market is segmented on the
basis of indication, age group, dosage form, distribution channel,
and region
By Type -
-
Tetracycline
-
Doxycycline
-
Chloramphenicol
-
Erythromycin
-
Fusidic acid
-
Sulfonamides
-
Trimethoprim
-
Macrolides
-
Lincosamides
-
Others
By Age Group -
-
Pediatric
-
Adults
By Dosage Form -
-
Tablet
-
Capsule
-
Injectables
By Distribution Channel -
-
Hospitals Pharmacies
-
Retail Pharmacies
-
Online pharmacies
By Region -
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
Browse
Full Report @
https://www.coherentmarketinsights.com/ongoing-insight/bacteriostatic-antibiotics-market-2307
Also,
Coherent Market Insights has a proprietary database of pipeline
biologics and biosimilars, called PHASE-XS. This database provides
analytical data in addition to the clinical information of ongoing
trials for biologics and biosimilars. An amalgamation of more than 30
parameters, PHASE-XS helps biotechnology and pharmaceutical companies
to analyze the market trend, competition, and market potential. For
more information or to access this database, kindly click on the
below link or contact at sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment